메뉴 건너뛰기




Volumn 21, Issue SUPPL. 7, 2010, Pages

What can the pathologist offer for optimal treatment choice?

Author keywords

HER2; Immunohistochemistry; In situ hybridization; Metastatic breast cancer; Oestrogen receptors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

EID: 78649386358     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq296     Document Type: Conference Paper
Times cited : (4)

References (12)
  • 1
    • 70049100788 scopus 로고    scopus 로고
    • International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy
    • Cardoso F, Bedard PL, Winer EP et al. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst 2009; 101: 1174-1181.
    • (2009) J Natl Cancer Inst , vol.101 , pp. 1174-1181
    • Cardoso, F.1    Bedard, P.L.2    Winer, E.P.3
  • 2
    • 68449084678 scopus 로고    scopus 로고
    • Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy
    • Guarneri V, Conte P. Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 2009; 14: 645-656.
    • (2009) Oncologist , vol.14 , pp. 645-656
    • Guarneri, V.1    Conte, P.2
  • 3
    • 71049154453 scopus 로고    scopus 로고
    • Third consensus on medical treatment of metastatic breast cancer
    • Besilija S, Bonneterre J, Burnstein HJ et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol 2009; 20: 1771-1785.
    • (2009) Ann Oncol , vol.20 , pp. 1771-1785
    • Besilija, S.1    Bonneterre, J.2    Burnstein, H.J.3
  • 4
    • 0020596899 scopus 로고
    • Variation in receptor status between primary and metastatic breast cancer
    • Holdaway IM, Bowditch JV. Variation in receptor status between primary and metastatic breast cancer. Cancer 1983; 52: 479-485.
    • (1983) Cancer , vol.52 , pp. 479-485
    • Holdaway, I.M.1    Bowditch, J.V.2
  • 5
    • 0022383773 scopus 로고
    • Heterogeneity in hormone receptor status in primaty and metastatic breast cancer
    • Osborne CK. Heterogeneity in hormone receptor status in primaty and metastatic breast cancer. Semin Oncol 1985; 12: 317-326.
    • (1985) Semin Oncol , vol.12 , pp. 317-326
    • Osborne, C.K.1
  • 6
    • 0026487215 scopus 로고
    • Sequential estrogen receptor determination from primary breast cancer and at relapse: prognostic and therapeutic relevance
    • Spataro V, Price K, Goldhirsch A et al. Sequential estrogen receptor determination from primary breast cancer and at relapse: prognostic and therapeutic relevance. Ann Oncol 1992; 3: 733-740.
    • (1992) Ann Oncol , vol.3 , pp. 733-740
    • Spataro, V.1    Price, K.2    Goldhirsch, A.3
  • 7
    • 0028071523 scopus 로고
    • Estrogen and progesterone receptor concordance between primary and recurrent breast cancer
    • Li BD, Byskosh A, Molteni A, Duda RB. Estrogen and progesterone receptor concordance between primary and recurrent breast cancer. J Surg Oncol 1994; 57: 71-77.
    • (1994) J Surg Oncol , vol.57 , pp. 71-77
    • Li, B.D.1    Byskosh, A.2    Molteni, A.3    Duda, R.B.4
  • 8
    • 0035421454 scopus 로고    scopus 로고
    • Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer
    • Simon R, Nocito A, Hübscher T et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001; 93: 1141-1146.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 1141-1146
    • Simon, R.1    Nocito, A.2    Hübscher, T.3
  • 9
    • 50649119930 scopus 로고    scopus 로고
    • Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management
    • Guarneri V, Giovannelli S, Ficarra G et al. Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management. Oncologist 2008; 13: 838-844.
    • (2008) Oncologist , vol.13 , pp. 838-844
    • Guarneri, V.1    Giovannelli, S.2    Ficarra, G.3
  • 10
    • 16844383643 scopus 로고    scopus 로고
    • Impact of metastatic estrogen receptor and progesterone receptor status on survival
    • Lower EE, Glass EL, Bradley DA et al. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 2005; 90: 65-70.
    • (2005) Breast Cancer Res Treat , vol.90 , pp. 65-70
    • Lower, E.E.1    Glass, E.L.2    Bradley, D.A.3
  • 11
    • 68349150810 scopus 로고    scopus 로고
    • Mammary development meets cancer genomics
    • Prat A, Perou CM. Mammary development meets cancer genomics. Nat Med 2009; 5: 842-844.
    • (2009) Nat Med , vol.5 , pp. 842-844
    • Prat, A.1    Perou, C.M.2
  • 12
    • 70849093383 scopus 로고    scopus 로고
    • Prognostic impact of discordance between triple receptor measurements in primary and recurrent breast cancer
    • Liedtke C, Gonzalez-Angulo AM, Pusztai L et al. Prognostic impact of discordance between triple receptor measurements in primary and recurrent breast cancer. Ann Oncol 2009; 20: 1953-1958.
    • (2009) Ann Oncol , vol.20 , pp. 1953-1958
    • Liedtke, C.1    Gonzalez-Angulo, A.M.2    Pusztai, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.